-----BEGIN PRIVACY-ENHANCED MESSAGE-----
Proc-Type: 2001,MIC-CLEAR
Originator-Name: webmaster@www.sec.gov
Originator-Key-Asymmetric:
 MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen
 TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB
MIC-Info: RSA-MD5,RSA,
 Aezuu/KA7+VPosQhFMZafPlv53mIAOZXTOz8oWteKu3+2VQK8OY7CvSuwbwsy/jw
 jk2WRl2rK78VLavZ4xQDsQ==

<SEC-DOCUMENT>0000950157-04-000829.txt : 20041108
<SEC-HEADER>0000950157-04-000829.hdr.sgml : 20041108
<ACCEPTANCE-DATETIME>20041108135450
ACCESSION NUMBER:		0000950157-04-000829
CONFORMED SUBMISSION TYPE:	3
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20041029
FILED AS OF DATE:		20041108
DATE AS OF CHANGE:		20041108

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			IMCOR PHARMACEUTICAL CO
		CENTRAL INDEX KEY:			0000761237
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				621742885
		STATE OF INCORPORATION:			NV
		FISCAL YEAR END:			1231

	BUSINESS ADDRESS:	
		STREET 1:		6175 LUSK BOULEVARD
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92121
		BUSINESS PHONE:		858 410-5601

	MAIL ADDRESS:	
		STREET 1:		6175 LUSK BLVD
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92121

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	PHOTOGEN TECHNOLOGIES INC
		DATE OF NAME CHANGE:	19970529

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			BRISTOL MYERS SQUIBB CO
		CENTRAL INDEX KEY:			0000014272
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		3
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-23553
		FILM NUMBER:		041125130

	BUSINESS ADDRESS:	
		STREET 1:		345 PARK AVE
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10154
		BUSINESS PHONE:		2125464000

	MAIL ADDRESS:	
		STREET 1:		345 PARK AVE
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10154

	FORMER NAME:	
		FORMER CONFORMED NAME:	BRISTOL MYERS CO
		DATE OF NAME CHANGE:	19891012
</SEC-HEADER>
<DOCUMENT>
<TYPE>3
<SEQUENCE>1
<FILENAME>primary_doc.xml
<DESCRIPTION>PRIMARY DOCUMENT
<TEXT>
<XML>
<?xml version="1.0"?>
<ownershipDocument>

    <schemaVersion>X0202</schemaVersion>

    <documentType>3</documentType>

    <periodOfReport>2004-10-29</periodOfReport>

    <noSecuritiesOwned>0</noSecuritiesOwned>

    <issuer>
        <issuerCik>0000761237</issuerCik>
        <issuerName>IMCOR PHARMACEUTICAL CO</issuerName>
        <issuerTradingSymbol>ICPH</issuerTradingSymbol>
    </issuer>

    <reportingOwner>
        <reportingOwnerId>
            <rptOwnerCik>0000014272</rptOwnerCik>
            <rptOwnerName>BRISTOL MYERS SQUIBB CO</rptOwnerName>
        </reportingOwnerId>
        <reportingOwnerAddress>
            <rptOwnerStreet1>345 PARK AVE</rptOwnerStreet1>
            <rptOwnerStreet2></rptOwnerStreet2>
            <rptOwnerCity>NEW YORK</rptOwnerCity>
            <rptOwnerState>NY</rptOwnerState>
            <rptOwnerZipCode>10154</rptOwnerZipCode>
            <rptOwnerStateDescription></rptOwnerStateDescription>
        </reportingOwnerAddress>
        <reportingOwnerRelationship>
            <isDirector>0</isDirector>
            <isOfficer>0</isOfficer>
            <isTenPercentOwner>1</isTenPercentOwner>
            <isOther>0</isOther>
        </reportingOwnerRelationship>
    </reportingOwner>

    <derivativeTable>
        <derivativeHolding>
            <securityTitle>
                <value>Series A Convertible Preferred Stock</value>
                <footnoteId id="F1"/>
            </securityTitle>
            <conversionOrExercisePrice>
                <value>0.27</value>
                <footnoteId id="F5"/>
            </conversionOrExercisePrice>
            <exerciseDate>
                <footnoteId id="F2"/>
            </exerciseDate>
            <expirationDate>
                <footnoteId id="F3"/>
            </expirationDate>
            <underlyingSecurity>
                <underlyingSecurityTitle>
                    <value>Common Stock</value>
                </underlyingSecurityTitle>
                <underlyingSecurityShares>
                    <value>16666667</value>
                    <footnoteId id="F4"/>
                </underlyingSecurityShares>
            </underlyingSecurity>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>D</value>
                </directOrIndirectOwnership>
            </ownershipNature>
        </derivativeHolding>
    </derivativeTable>

    <footnotes>
        <footnote id="F1">Bristol-Myers Squibb Company (BMS) directly owns 4,500 shares of the Series A Convertible Preferred Stock  (&quot;Preferred Stock&quot;) reported herein.</footnote>
        <footnote id="F2">The Preferred Stock may be converted into the Issuer's Common Stock under the following circumstances: (i) by BMS at any time after July 29, 2005 or (ii) by the Issuer at any time after October 29, 2005 provided that the closing price of the Issuer's Common Stock exceeds the conversion price of $0.27 by 50% for any ten (10) consecutive trading days.</footnote>
        <footnote id="F3">Not applicable.</footnote>
        <footnote id="F4">Each share of Preferred Stock is convertible into approximately 3,703.7 shares of Common Stock;  in the aggregate, the 4,500 shares of Preferred Stock owned by BMS are convertible into approximately 16,666,667 shares of the Issuer's Common Stock.</footnote>
        <footnote id="F5">This initial conversion price is subject to adjustments for dilution resulting from stock splits and combinations, certain dividends and distributions, and the reorganization, reclassification or merger of the Issuer, in each case as set forth in the Certificate of Designation.</footnote>
    </footnotes>

    <ownerSignature>
        <signatureName>/s/ Sandra Leung, Vice President and Corporate Secretary</signatureName>
        <signatureDate>2004-11-08</signatureDate>
    </ownerSignature>
</ownershipDocument>

</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
-----END PRIVACY-ENHANCED MESSAGE-----